Semiconductor News & Analysis Feed

The US technology sector is experiencing a new wave of growth, with artificial intelligence development serving as the core driver. NVIDIA, as the leading GPU manufacturer, is collaborating with key AI companies like OpenAI to deploy AI infrastructure on a large scale by 2030, significantly propelli

Certara has partnered with NVIDIA to enhance its AI platform for drug discovery and development by integrating NVIDIA's BioNeMo Agent Toolkit. This collaboration merges Certara's biosimulation software, regulatory expertise, and datasets with AI-driven agents, aiming to accelerate the drug developme

Simulations Plus has partnered with NVIDIA to advance its AI-native platform Composer by integrating the NVIDIA BioNeMo Agent Toolkit, aiming to accelerate model-informed drug development. This collaboration extends their prior work in GPU-accelerated simulation and AI-assisted modeling into agentic

NVIDIA has entered a strategic collaboration with Simulation Plus to apply GPU acceleration and AI-assisted workflows in drug development and quantitative systems pharmacology. This move extends NVIDIA's influence into life sciences, building on its existing presence in AI and data center computing.